Notice2024-28045
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Previously Approved Collection; Registration for Controlled Substances Act Data-Use Request
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 29, 2024
Issuing agencies
Justice Department
Abstract
The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 230 (Friday, November 29, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 230 (Friday, November 29, 2024)]
[Notices]
[Pages 94763-94764]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-28045]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0059]
Agency Information Collection Activities; Proposed eCollection
eComments Requested; Extension of a Previously Approved Collection;
Registration for Controlled Substances Act Data-Use Request
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 30-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995.
DATES: Comments are encouraged and will be accepted for 30 days until
December 30, 2024.
FOR FURTHER INFORMATION CONTACT: If you have comments especially on the
estimated public burden or associated response time, suggestions, or
need a copy of the proposed information collection instrument with
instructions or additional information, please contact Heather E.
Achbach, Regulatory Drafting and Policy Support Section, Drug
Enforcement Administration; Mailing Address: 8701 Morrissette Drive,
Springfield, Virginia 22152; Telephone: (571) 776-3882; Email:
<a href="/cdn-cgi/l/email-protection#0e4a4b4f205e5c4f4e6a6b6f20696178"><span class="__cf_email__" data-cfemail="256160640b757764654140440b424a53">[email protected]</span></a> or <a href="/cdn-cgi/l/email-protection#e1a9848095898493cfa4cfa0828983808289a1858480cf868e97"><span class="__cf_email__" data-cfemail="d79fb2b6a3bfb2a5f992f996b4bfb5b6b4bf97b3b2b6f9b0b8a1">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on September 24, 2024, at
89 FR 77895, allowing for a 60-day comment period. Written comments and
suggestions from the public and affected agencies concerning the
proposed collection of information are encouraged. Your comments should
[[Page 94764]]
address one or more of the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be
collected; and/or
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Written comments and recommendations for this information
collection should be submitted within 30 days of the publication of
this notice on the following website <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>.
Find this particular information collection by selecting ``Currently
under 30-day Review--Open for Public Comments'' or by using the search
function and entering either the title of the information collection or
the OMB Control Number 1117-0059. This information collection request
may be viewed at <a href="http://www.reginfo.gov">www.reginfo.gov</a>. Follow the instructions to view
Department of Justice, information collections currently under review
by OMB.
DOJ seeks PRA authorization for this information collection for
three (3) years. OMB authorization for an ICR cannot be for more than
three (3) years without renewal. The DOJ notes that information
collection requirements submitted to the OMB for existing ICRs receive
a month-to-month extension while they undergo review.
Overview of This Information Collection:
1. Type of Information Collection: Extension of a previously
approved collection.
2. Title of the Form/Collection: Registration for CSA Data-Use
Request.
3. Agency form number, if any, and the applicable component of the
Department of Justice sponsoring the collection: No form number is
associated with this collection. The applicable component within the
Department of Justice is the Drug Enforcement Administration, Diversion
Control Division.
4. Affected public who will be asked or required to respond, as
well as a brief abstract:
Affected public (Primary): Business or other for-profit.
Affected public (Other): Not-for-profit institutions; Federal,
State, Local, and tribal governments.
5. Abstract: In accordance with the Controlled Substance Act (CSA),
every person who manufactures, distributes, dispenses, conducts
research with, imports, or exports any controlled substance to obtain a
registration issued by the Attorney General. 21 U.S.C. 822, 823, and
957. While DEA registrants are able to self-verify their registration
status, non-registrants do not have an obligation to register under the
CSA, and therefore does not have an automatic means to verify the
registration of a DEA-registrant. Non-registrants have obligations to
verify the registration statuses before doing things such as hiring
practitioners, paying for controlled substance prescriptions covered by
Medicaid or Medicare, and other means that are apart of commerce. This
proposed collection would allow non-registrants to register for access
to the CSA Database System, which gives the names and registration
statuses of all DEA-registrants. Applicants would be required to re-
apply annually by completing this form and submitting to DEA.
6. Obligation to Respond: Required to obtain or retain benefits.
7. Total Estimated Number of Respondents: 9,000.
8. Estimated Time per Respondent: 15 minutes.
9. Frequency: 1 per year.
10. Total Estimated Annual Time Burden: 2,250 hours.
11. Total Estimated Annual Other Costs Burden: $0.
If additional information is required, contact: Darwin Arceo,
Department Clearance Officer, Policy and Planning Staff, Justice
Management Division, United States Department of Justice, Two
Constitution Square, 145 N Street NE, 4W-218 Washington, DC 20530.
Dated: November 25, 2024.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2024-28045 Filed 11-27-24; 8:45 am]
BILLING CODE 4410-09-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 29, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.